Westwood Holdings Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-209,099
Closed -$1.92M – 506
2024
Q3
$1.92M Buy
+209,099
New +$1.73M 0.01% 337
2024
Q1
– Sell
-69,889
Closed -$1.51M – 496
2023
Q4
$1.51M Buy
69,889
+8,072
+13% +$149K 0.01% 338
2023
Q3
$1.15M Buy
61,817
+9,263
+18% +$216K 0.01% 335
2023
Q2
$1.33M Buy
52,554
+7,462
+17% +$188K 0.01% 329
2023
Q1
$1.17M Buy
+45,092
New +$1.21M 0.01% 341

Other funds holding TDOC

Westwood Holdings Group's TDOC Position: Q4 2024 in Review

Westwood Holdings Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 209,099 shares — an estimated $1.92M sold.

Westwood Holdings Group first reported a position in TDOC in Q1 2023 and held it in 5 quarters. The position peaked at $1.92M in Q3 2024. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Westwood Holdings Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Westwood Holdings Group sold 209,099 Teladoc Health shares in Q4 2024, an estimated $1.92M.
  • Westwood Holdings Group first reported a position in Teladoc Health in Q1 2023 and held it in 5 quarters.
  • Westwood Holdings Group's Teladoc Health position peaked at $1.92M in Q3 2024.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Westwood Holdings Group's 13F filing for Q4 2024, filed 14 Feb 2025.